Evidence map›Paper›PMID 35349033›Full record

ArticleMedical & biological engineering & computing2022

Assessment of the risk factors of type II diabetes using ACO with self-regulative update function and decision trees by evaluation from Fisher's Z-transformation.

A Sheik Abdullah

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A Sheik AbdullahSchool of Computer Science Engineering, Vellore Institute of Technology, Chennai, Tamil Nadu, India. aa.sheikabdullah@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type II diabetes is considered to be one of the persistent diseases which is the cause of death and disability in many regions. The objective of this research work is to apply an improved combination of the ant colony optimization (ACO) algorithm with decision trees (J48) for accessing and evaluating the risk factors related to type II diabetes. The model developed concerning the routine and deviated values for each attribute corresponding to type II diabetes. Experimental evaluation has been made with the modified self-regulative function of ACO with enhancement in pheromone update rule to make the ants in the search space converge at the best optimal path. In addition to this, continuous assessment has been made with probabilistic function by the construction of new solution incrementally made by the ants through feature by feature analysis. From the results, it has been observed that the risk factors corresponding to type II diabetes are postprandial plasma glucose (PPG), fasting plasma glucose (FPG), and glycosylated hemoglobin (A1c) which has selected with an improved accuracy than that of the existing methods and algorithms. The efficiency of prediction has been tested using Fisher's Z-transformation with a 95% of confidence level for upper and lower bounds. From the inference, it has been observed that there exists a strong correlation among the risk factors PPF and FPG with significance in P-value for the risk corresponding to type II diabetes. Hence, predictive analytics with improvement in ACO with C4.5 decision tree algorithm can also be deployed for accessing the risk factors related to NCD such as cancer, heart disease, and kidney diseases.

Indexed as

Diabetes Mellitus, Type 2AlgorithmsBlood GlucoseDecision TreesHumansRisk FactorsBlood GlucoseAnt colony optimizationC4.5 decision treesData analyticsData classificationFisher’s Z-transformationSwarm intelligenceType II diabetes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.